Technical Analysis for HYPR - Hyperfine, Inc.
Grade | Last Price | % Change | Price Change |
---|---|---|---|
F | 0.98 | 0.14% | 0.00 |
HYPR closed up 0.14 percent on Friday, November 1, 2024, on 30 percent of normal volume. The price action carved out a bearish shooting star candlestick pattern. That may indicate a downside reversal. Look for price to trade beneath the low of the shooting star for confirmation.
Earnings due: Nov 12
*** please verify all earnings dates ***ADX | Long Term | Intermediate Term | Short Term |
---|---|---|---|
Weak or Absent | Down | Down | Flat |
Date | Alert Name | Type | % Chg |
---|---|---|---|
20 DMA Resistance | Bearish | 0.00% | |
Shooting Star Candlestick | Bearish | 0.00% | |
180 Bearish Setup | Bearish Swing Setup | 0.00% | |
Bollinger Band Squeeze | Range Contraction | 0.00% | |
Doji - Bearish? | Reversal | 0.00% | |
Oversold Stochastic | Weakness | 0.00% | |
Stochastic Buy Signal | Bullish | 0.14% | |
Pocket Pivot | Bullish Swing Setup | 0.14% | |
Bollinger Band Squeeze | Range Contraction | 0.14% | |
Narrow Range Bar | Range Contraction | 0.14% |
Alert | Time |
---|---|
60 Minute Opening Range Breakdown | about 23 hours ago |
20 DMA Resistance | 1 day ago |
10 DMA Resistance | 1 day ago |
Rose Above 20 DMA | 1 day ago |
Rose Above Previous Day's High | 1 day ago |
Get a Trading Assistant
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 11/12/2024
Hyperfine was founded with a vision to save lives by making Magnetic Resonance Imaging (MRI) more accessible and affordable. Hyperfine's portable Swoop™ system is the world's first FDA-cleared bedside MRI system. Hyperfine was founded in 2014 by Jonathan Rothberg, Ph.D., a serial entrepreneur and the founder or co-founder of numerous other innovative companies, including CuraGen, 454 Life Sciences, Ion Torrent, RainDance Technologies, ClariFI, Quantum-Si, AI Therapeutics, Butterfly Network, 4Catalyzer, and 4Bionics. In 2015, Rothberg was awarded the National Medal of Technology and Innovation by President Obama for inventing and commercializing DNA sequencing.
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Classification
Sector: Healthcare
Industry: Medical Devices
Keywords: Life Sciences Biology Natural Sciences FDA MRI Magnetic Resonance Magnetic Resonance Imaging DNA Sequencing Jonathan Rothberg
Indicator | Bull Case | Neutral / Hold | Bear Case |
---|---|---|---|
50 DMA | |||
200 DMA | |||
ADX Trend | |||
Oversold / Overbought | |||
Relative Strength |
Indicator | Value |
---|---|
52 Week High | 1.45 |
52 Week Low | 0.7613 |
Average Volume | 108,376 |
200-Day Moving Average | 1.00 |
50-Day Moving Average | 1.01 |
20-Day Moving Average | 0.99 |
10-Day Moving Average | 0.98 |
Average True Range | 0.04 |
RSI (14) | 46.52 |
ADX | 7.57 |
+DI | 19.87 |
-DI | 19.89 |
Chandelier Exit (Long, 3 ATRs) | 0.94 |
Chandelier Exit (Short, 3 ATRs) | 1.06 |
Upper Bollinger Bands | 1.02 |
Lower Bollinger Band | 0.96 |
Percent B (%b) | 0.29 |
BandWidth | 6.19 |
MACD Line | -0.01 |
MACD Signal Line | -0.01 |
MACD Histogram | -0.001 |
Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
---|---|---|---|---|---|
Resistance 4 (R4) | 1.02 | ||||
Resistance 3 (R3) | 1.02 | 1.01 | 1.01 | ||
Resistance 2 (R2) | 1.01 | 1.00 | 1.01 | 1.01 | |
Resistance 1 (R1) | 0.99 | 0.99 | 0.99 | 0.99 | 1.01 |
Pivot Point | 0.99 | 0.99 | 0.98 | 0.98 | 0.99 |
Support 1 (S1) | 0.97 | 0.98 | 0.97 | 0.97 | 0.95 |
Support 2 (S2) | 0.96 | 0.97 | 0.96 | 0.95 | |
Support 3 (S3) | 0.95 | 0.96 | 0.95 | ||
Support 4 (S4) | 0.94 |